Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response study of once-daily nitisinone in alkaptonuria
2012-005340-24Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nitisinone in alkaptonuria (AKU) (2 arms), sponsored by University of Liverpool. Primary endpoint: Primary: Change in 24-hour urinary homogentisic acid excretion at 4 weeks. Started Jan 2013; status: completed.
02
Drugs
nitisinone
03
Conditions
alkaptonuria (AKU)
Beyond the preview
Go deeper on 2012-005340-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005340-24.